Navigation Links
OncoGenex and Isis Announce OGX-011 Data to be Presented at ASCO

facts and factors currently known by Isis. As a result, you are cautioned not to rely on these forward-looking statements. These and other risks concerning Isis' programs are described in additional detail in Isis' annual report on Form 10-K for the year ended December 31, 2006, and its quarterly report on Form 10-Q for the quarter ended March 31, 2007, which are on file with the SEC. Copies of this and other documents are available from the Company.

    Isis Pharmaceuticals, Ibis Biosciences and Ibis T5000 are registered

    trademarks or trademarks of Isis Pharmaceuticals, Inc.


CONTACT: OncoGenex Contact: Scott Cormack, President & CEO, (604) 630-5400; OncoGenex Media Contact: Jason Spark, Porter Novelli Life Sciences, (619) 849-6005; Isis Contact: Kate Corcoran, Vice President, Corporate Development, (760) 603-2331

CONTACT: OncoGenex Contact: Scott Cormack, President & CEO, (604)630-5400; OncoGenex Media Contact: Jason Spark, Porter Novelli LifeSciences, (619) 849-6005; Isis Contact: Kate Corcoran, Vice President,Corporate Development, (760) 603-2331

Ticker Symbol: (NASDAQ-NMS:ISIS)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2 3 4

Related medicine technology :

1. OncoGenex Technologies Announces Phase II Data of OGX-011 in Metastatic Breast Cancer at American Association for Cancer Research 2007 Annual Meeting
2. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
3. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
4. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
7. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
8. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
9. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. Protox Announces Positive Clinical Data from Prostate Cancer Study

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: OncoGenex and Isis Announce OGX Data Presented ASCO
(Date:11/30/2009)... Nov. 30 According to Millennium R...al technology market intelligence, the nearly $1.2...by almost 5% over 2008 as patients chose to delay ...isis. The market will, however, begin recovery in ...ecession growth rates of over 15%. MRG,s facial in...
(Date:11/30/2009)... Minimally-invasive procedures are ...articularly in oncology, cardiology and women,s he...-guided navigation expected to reach $600 million ...ffered by minimally-invasive procedures, including...omfort and faster patient throughput. ,, (Log...
(Date:11/30/2009)... Nov. 30 Decision Resources, one o...focusing on pharmaceutical and healthcare issues, ...n Russia will grow nine percent annually over the ... 2013. This growth will be driven mainly by increa...d use of more-expensive therapies like pegylated i...
Breaking Medicine Technology:Facial Injectables Emerge From the Recession 2Facial Injectables Emerge From the Recession 3Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 2Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 3Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 4Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 5Russia's Hepatitis C Virus Drug Market Will Grow Nine Percent Annually, Reaching $327 Million by 2013 2Russia's Hepatitis C Virus Drug Market Will Grow Nine Percent Annually, Reaching $327 Million by 2013 3Houston Dermatologists to Round Up for Sun Safety at World Class LPGA Tour Championship 61451 1Houston Dermatologists to Round Up for Sun Safety at World Class LPGA Tour Championship 61451 2US Farms Inc Announces Completion of Construction for New 3000 Square Foot Greenhouse Shipping and Packing Facility for Nursery Division 61448 1US Farms Inc Announces Completion of Construction for New 3000 Square Foot Greenhouse Shipping and Packing Facility for Nursery Division 61448 2Cadus Reports Third Quarter 2009 Results 14855 1Cadus Reports Third Quarter 2009 Results 14855 2Cadus Reports Third Quarter 2009 Results 14855 3Cadus Reports Third Quarter 2009 Results 14855 4Cadus Reports Third Quarter 2009 Results 14855 5
...URY, N.J., March 25 Amicus Therapeutics (Nasdaq: ... 2009 of United States Patent No. 7,501,439, title...." The patent covers the tartrate salt form of is...investigational drug Plicera(TM) (afegostat tartra...ase. The patent will expire in 2027. , , John ...
...udy results suggest the true prevalence of dementi...rticularly in the world,s least developed regions ...y presentations at 24th Conference of Alzheimer,s ...nomic, social and personal impact of Alzheimer,s a...o treat and prevent the devastating brain disorder...
Other Medicine Technology:Amicus Therapeutics Announces Issuance of New Plicera(TM) Composition of Matter Patent 2Amicus Therapeutics Announces Issuance of New Plicera(TM) Composition of Matter Patent 3Worldwide Cost Estimate for Alzheimer's and Dementia Is US$315.4 Billion 2Worldwide Cost Estimate for Alzheimer's and Dementia Is US$315.4 Billion 3Worldwide Cost Estimate for Alzheimer's and Dementia Is US$315.4 Billion 4Worldwide Cost Estimate for Alzheimer's and Dementia Is US$315.4 Billion 5Worldwide Cost Estimate for Alzheimer's and Dementia Is US$315.4 Billion 6
(Date:11/30/2009)...mission leaves them without treatment for blood-bo..., Nov. 30 (HealthDay News) -- Many medical student...lood-borne diseases, but they often fail to alert ...f infection, a new study has found. , The resea...ical centers and found that 415 -- 59 percent -- h...
(Date:11/30/2009)..., , NEW ORLEANS, Nov. 30 /PRNewswire-USNews...mployees of the global corporation Sodexo will hol... Facilities and Maintenance headquarters, 3800 Des...le leave policy and arbitrary disciplinary policie... care for an ill family member. Sodexo employees w...
(Date:11/30/2009)..., , CHARLTON, Mass., Nov. 30 ... announce the addition of Family Practice physicia... Monika Mathur to its Charlton practice. ,, T...icians, coming from the Fallon Clinic, will soon j...althCare at Charlton medical office building under...
(Date:11/30/2009)... There is a tiny period of time between the regist...d and our conscious recognition of it ― betw...nize it as an apple. Our minds lag behind our eyes...actions to the world around us? , Some estimat... others say 500 milliseconds. A new study by Tel A...
(Date:11/30/2009)...anguage, social skills improve with specially desi...v. 30 (HealthDay News) -- A special, intensive ear...ucceeded in boosting IQ along with children,s lang...hen done in this fashion, many children are able t...ine Dawson, lead author of the study, published on...
Breaking Medicine News(10 mins):Health News:Med Students Often Fail to Report Needlestick Injuries 2Health News:As H1NI Hits New Orleans in Force: School Custodians to Hold Rally to Call on Contractor to Stop Penalizing Workers Coping With Illness 2Health News:Family Practice Physicians Martin Devine, Leah Doret, Elizabeth Fuller and Monika Mathur Join Harrington Physician Services in Charlton 2Health News:Family Practice Physicians Martin Devine, Leah Doret, Elizabeth Fuller and Monika Mathur Join Harrington Physician Services in Charlton 3Health News:Now you see it, now you know you see it 2Health News:Working Intensely Early on May Help Autistic Kids 2Health News:Working Intensely Early on May Help Autistic Kids 3Health News:Working Intensely Early on May Help Autistic Kids 4
...tists have now uncovered graphic evidence that sug...4 with the occurrence of herpes simplex infection/...he results of the research. In older individuals,...ty that occurrence of herpes infection earlier in ...
...pound derived from the bark of a tree could help p..., says a new study.// The new molecule tazo...ed in Madagascar's eastern rain forest, reported s...land in the world and is home to five percent of t...
...go: Use of the drug pexelizumab immediately before...asty for certain heart attack patients did not hav...lacebo, according to a study in the issue of JAMA....ram following a heart attack) is a major public he...
...ding to a new study in the January 3 issue of the ...all cost of patients' time spent on cancer care in...iagnosis. Several studies have estimated the d...d from care, waiting for appointments, and receivi...
...food - quick, convenient and cheap, which, we all ...uble cheeseburger costs less than a head of lettuc...tables are one of the keys to good health; Barbara...y-dense foods. But Volumetrics and similar health-...
...go: A set of guidelines have been developed that c...or children with cerebrospinal fluid pleocytosis (...than normal), reducing unnecessary hospitalization...rospinal fluid (CSF) pleocytosis, the majority of ...
Other Medicine News:Health News:Herpes Simplex and Alzheimer’s Disease Linked to Single Gen 2Health News:Herpes Simplex and Alzheimer’s Disease Linked to Single Gen 3Health News:Herpes Simplex and Alzheimer’s Disease Linked to Single Gen 4Health News:Drug Therapy Offers Little Benefit for Some Patients Undergoing Angioplasty or Stent Procedure 2Health News:Cancer Care-Patient's Time Costs Studied 2Health News:Clinical Guidelines Help Identify Which Children at Risk of Bacterial Meningitis 2
DataMate Mother/Father/Infant Laser Wristbands
DataMate Laser Label/Wristband Sheet
PrimeBand® Wristbands
Securline® Bar Code Band Wristbands
Medicine Products: